Sirio Pharma Co., Ltd. (SHE:300791)

Sirio Pharma Revenue

Sirio Pharma had revenue of 1.01B CNY in the quarter ending September 30, 2026, a decrease of -18.94%. This brings the company's total for the last twelve months to 4.04B, down -9.36% year-over-year. In the year 2025, Sirio Pharma had annual revenue of 4.26B with 1.23% growth. That makes Sirio Pharma the 10,152nd largest company in the world by revenue and 1,648th in China.

• Revenue (ttm): 4.04B
• Revenue Growth: -9.36%
• P/S Ratio: 1.27
• Revenue / Employee: 1.45M
• Employees: 2,776
• Market Cap: 5.17B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.71B 40.2%
• Americas 1.55B 36.4%
• Europe 755.30M 17.7%
• Other Areas 241.70M 5.7%

Fiscal year ended Dec 31, 2025 See the full Sirio Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.26B	51.84M	1.23%
Dec 31, 2024	4.21B	629.04M	17.56%
Dec 31, 2023	3.58B	1.07B	42.87%
Jan 1, 2023	2.51B	138.31M	5.84%
Dec 31, 2021	2.37B	302.13M	14.62%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error